Arbutus Biopharma (ABUS) Interest Coverage Ratio (2017 - 2026)

Arbutus Biopharma has disclosed Interest Coverage Ratio across 10 years of filings, most recently posting 9935.76 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 9935.76, up 1182.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 1819.15 (up 366.31% YoY), and the FY2025 annual result was 393.4, up 29.38% from the prior year.
• Interest Coverage Ratio came in at 9935.76 for Q1 2026 at Arbutus Biopharma, up from 293.89 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 9935.76 in Q1 2026 to a low of 917.82 in Q1 2025.
• The 5-year median for Interest Coverage Ratio is 293.89 (2025), against an average of 283.59.
• Across the five-year window, Interest Coverage Ratio sank 1028.81% in 2023 and surged 1182.54% in 2026, its largest moves.
• Arbutus Biopharma's Interest Coverage Ratio stood at 73.02 in 2022, then sank by 545.78% to 471.52 in 2023, then grew by 1.5% to 464.43 in 2024, then soared by 36.72% to 293.89 in 2025, then surged by 3480.79% to 9935.76 in 2026.
• The last three Interest Coverage Ratio figures came in at 9935.76 (Q1 2026), 293.89 (Q4 2025), and 376.48 (Q3 2025), per Business Quant data.